Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shares notification

31 Jan 2007 09:37

ReNeuron Group plc31 January 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer RENEURON GROUP PLCof existing shares to which voting rights are attached 2. Reason for the notification (please tick the appropriate box or boxes)An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which rioting rights are attached An event changing the breakdown of voting rights 3. Full name of person(s) subject to the SAAD INVESTMENTS COMPANY LIMITED notification obligation4. Full name of shareholder(s) (if different from 3.) Vidacos Nominees Ltd (Citigroup Global AWAL)5. Date of the transaction and date on which the Not specified. threshold is crossed or reached6. Date on which issuer notified 30 January 2007 A: Voting rights attached to sharesClass/type Situation Resulting situation after the triggering transaction vi of shares previous to the Triggering if possible transactionusing the ISIN Number of Number Number of Number of voting rights % of voting rightsCODE Shares shares ix of Voting Rights Direct Direct Indirect Direct Indirect Ordinary Shares Not Not 18,950,000 18,950,000 0 15.988% 0 specified specified B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration Exercise/Conversion Number of voting rights % of voting date Period/Date that may be acquired if rightsinstrument the instrument is - exercised/converted N/A - - - - Total (A+B)Number of voting rights % of voting rights 18,950,000 15.988% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable None specified. Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A12. Date on which proxy holder will cease to hold voting N/Arights: 13. Additional information: Recent acquisition. 14. Contact name: Michael Hunt, CEO15. Contact telephone number: 01483 302560 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Dec 20204:36 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSNotification of Major Holdings
17th Dec 202012:44 pmRNSNotification of Major Holdings
17th Dec 20207:00 amRNSNotification of Major Holdings
17th Dec 20207:00 amRNSNotification of Allowance granted for US Patent
16th Dec 20205:37 pmRNSNotification of Major Holdings
16th Dec 20202:17 pmRNSNotification of Major Holdings
16th Dec 20207:00 amRNSNotification of Major Holdings
11th Dec 202010:33 amRNSResult of General Meeting and Total Voting Rights
11th Dec 20207:00 amRNSResult of Open Offer
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
25th Nov 20204:36 pmRNSPrice Monitoring Extension
25th Nov 20202:06 pmRNSSecond Price Monitoring Extn
25th Nov 20202:00 pmRNSPrice Monitoring Extension
25th Nov 202011:05 amRNSSecond Price Monitoring Extn
25th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
24th Nov 20202:06 pmRNSSecond Price Monitoring Extn
24th Nov 20202:00 pmRNSPrice Monitoring Extension
24th Nov 20207:15 amRNSResult of Placing and Subscription and GM Notice
24th Nov 20207:00 amRNSInterim Results
23rd Nov 20205:42 pmRNSProposed Placing, Subscription and Open Offer
2nd Nov 20207:00 amRNSTotal Voting Rights
10th Sep 20203:59 pmRNSResult of AGM
10th Sep 20207:00 amRNSAGM Trading Update
1st Sep 20207:00 amRNSBlock Listing Review and Total Voting Rights
18th Aug 20207:00 amRNSPosting of Annual Report and Notice of AGM
12th Aug 20207:00 amRNSChanges to Non-Executive Board
3rd Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:00 amRNSNotification of Allowance granted for US Patent
20th Jul 20207:00 amRNSPreliminary Results
14th Jul 20203:06 pmRNSNotification of Major Holdings
29th Jun 20207:00 amRNSFurther Positive Data in Retinal Clinical Trial
25th Jun 20207:00 amRNSNew Exosome Research Collaboration
17th Jun 20207:00 amRNSRegulatory Approvals and Programme Update
7th May 20207:00 amRNSCTX cell line shows further potential
7th Apr 20202:06 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
7th Apr 202011:06 amRNSSecond Price Monitoring Extn
7th Apr 202011:00 amRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSExosome Research Collaboration
3rd Apr 20207:00 amRNSCOVID-19 Update
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:39 pmRNSPrice Monitoring Extension
2nd Mar 20207:00 amRNSBlock Listing Review and Total Voting Rights
24th Feb 20207:00 amRNSPositive long-term data in retinal clinical trial
17th Feb 20207:00 amRNSPositive Phase 2a stroke clinical data published
12th Feb 20207:02 amRNSNotification of Major Holdings
12th Feb 20207:01 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.